Niklas Klümper
16PUBLICATIONS
93CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (16)
Sort by Publication Date:
|Jul 09, 2025
The Antibody-Drug Conjugate Sacituzumab Govitecan (IMMU-132) Represents a Potential Novel Therapeutic Strategy in Cholangiocarcinoma.Racha Hosni, Niklas Klümper, Christine Sanders
|Jun 13, 2025
The Antibody-Drug Conjugate Sacituzumab Govitecan (IMMU-132) Represents a Potential Novel Therapeutic Strategy in Cholangiocarcinoma.Racha Hosni, Niklas Klümper, Christine Sanders
|Dec 16, 2024
C-Reactive Protein Facilitates Premetastatic Niche Formation in the Lungs.Jonas Saal, Niklas Klümper, Michael Hölzel
|Apr 24, 2024
NECTIN4 Amplification Is Frequent in Solid Tumors and Predicts Enfortumab Vedotin Response in Metastatic Urothelial Cancer.Niklas Klümper, Ngoc Khanh Tran, Stefanie Zschäbitz
|Feb 10, 2024
Feasibility of Monitoring Response to Metastatic Prostate Cancer Treatment with a Methylation-Based Circulating Tumor DNA Approach.Thomas Büttner, Dimo Dietrich, Romina Zarbl
|Jan 04, 2024
Adipocyte Precursor-Derived NRG1 Promotes Resistance to FGFR Inhibition in Urothelial Carcinoma.Sana Hosni, Viola Kilian, Niklas Klümper
Pageof 3
Frequent Collaborators
10 joint publications
Jörg Ellinger
7 joint publications
Michael Hölzel
6 joint publications
Marieta Toma
5 joint publications
Markus Eckstein
5 joint publications
Glen Kristiansen
4 joint publications
Abdullah Alajati
3 joint publications
Philipp Krausewitz
3 joint publications
Oliver Hahn
3 joint publications
Thomas Büttner
3 joint publications
Damian J Ralser
